YKL-40 Levels in Rheumatoid Arthritis and Their Correlation with Disease Activity: A Meta-analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Young Ho | - |
dc.contributor.author | Song, Gwan Gyu | - |
dc.date.accessioned | 2021-09-01T04:57:13Z | - |
dc.date.available | 2021-09-01T04:57:13Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-10 | - |
dc.identifier.issn | 2093-940X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/62656 | - |
dc.description.abstract | Objective. To examine the relationship of serum/plasma YKL-40 levels with rheumatoid arthritis (RA) and their correlation with RA activity and rheumatoid factor (RF) level. Methods. We performed a meta-analysis comparing the serum/plasma YKL-40 levels between patients with RA and controls and examined the correlation coefficients of the circulating YKL-40 level with the RF level and RA activity based on the 28-joint disease activity score (DAS28), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) level. Results. Nine studies (707 patients with RA and 1,041 controls) were included in the meta-analysis. The YKL-40 levels were significantly higher in the RA group than in the control group (standardized mean difference [SMD] = 1.071, 95% confidence interval [CI] = 0.726 similar to 1.417, p<0.001). Stratification by ethnicity showed significantly elevated YKL-40 levels in the RA groups from European, Asian, North American, and Arab populations. The YKL-40 level was significantly higher in the RA group than in the control group in both age- and sex-matched and only age- matched populations (SMD=0.937, 95% CI=0.554 similar to 1.320, p<0.001; SMD=2.951, 95% CI=1.389 similar to 4.512, p<0.001, respectively). Subgroup analysis by sample size showed significantly increased YKL-40 levels in the RA group in both small (n<100) and large (n > 100) populations. Meta-analysis of correlation coefficients showed a significant positive correlation between the YKL-40 levels and DAS28, ESR, CRP level, and RF level ( DAS28: correlation coefficient=0.381, 95% CI=0.044 similar to 0.640, p=0.028; RF level: correlation coefficient=0.341, 95% CI=0.176 similar to 0.487, p<0.001). Conclusion. The circulating YKL-40 levels are high in patients with RA and positively correlate with RA activity and RF level. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN COLL RHEUMATOLOGY | - |
dc.subject | HUMAN CARTILAGE GP-39 | - |
dc.subject | SERUM YKL-40 | - |
dc.subject | INFLAMMATION | - |
dc.title | YKL-40 Levels in Rheumatoid Arthritis and Their Correlation with Disease Activity: A Meta-analysis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Young Ho | - |
dc.identifier.doi | 10.4078/jrd.2019.26.4.257 | - |
dc.identifier.wosid | 000523560600005 | - |
dc.identifier.bibliographicCitation | JOURNAL OF RHEUMATIC DISEASES, v.26, no.4, pp.257 - 263 | - |
dc.relation.isPartOf | JOURNAL OF RHEUMATIC DISEASES | - |
dc.citation.title | JOURNAL OF RHEUMATIC DISEASES | - |
dc.citation.volume | 26 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 257 | - |
dc.citation.endPage | 263 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002508888 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Rheumatology | - |
dc.relation.journalWebOfScienceCategory | Rheumatology | - |
dc.subject.keywordPlus | HUMAN CARTILAGE GP-39 | - |
dc.subject.keywordPlus | SERUM YKL-40 | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordAuthor | YKL-40 | - |
dc.subject.keywordAuthor | Rheumatoid arthritis | - |
dc.subject.keywordAuthor | Activity | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.